News about Global Pharma

Analog Devices Receives FDA Clearance and Launches Sensinel Cardiopulmonary Management System

This compact wearable device represents a breakthrough in chronic disease management, particularly for conditions like heart failure, and marks the company's first FDA clearance in its 59-year history.

Global Pharma | 06/03/2024 | By Abha |  396

Cytovale Appoints Christopher Slachta as Chief Operating Officer

With more than 20 years of experience in the medical device and diagnostic industry, Slachta will lead operations as Cytovale ramps up production of its FDA-cleared rapid sepsis diagnosis test — IntelliSep®.

Global Pharma | 05/03/2024 | By Manvi |  426

Haemonetics Announces Definitive Agreement to Acquire Attune Medical

The acquisition is subject to customary closing conditions and is expected to be completed in the first quarter of Haemonetics' fiscal year 2025.

Global Pharma | 05/03/2024 | By Manvi |  976

Ariceum Therapeutics Launches Cutting-Edge Laboratory Facility in Berlin Headquarters

These cutting-edge facilities are dedicated to advancing the company's next-generation radiopharmaceutical pipeline candidates and facilitating the transition of emerging products into clinical trials.

Global Pharma | 05/03/2024 | By Abha |  742

BridgeBio Pharma and Bayer Partner to Bring Acoramidis to European Market

Under this agreement, BridgeBio is set to receive up to USD 310 million USD, including upfront and near-term milestone payments, along with additional undisclosed sales milestones.

Global Pharma | 05/03/2024 | By Abha |  972

Affidea Group Enters into Binding Agreement to Acquire MedEuropa Romania

Affidea Group, Europe's largest provider of advanced diagnostics, multi-speciality polyclinics and Centres of Excellence, announced that it has entered into a binding agreement to acquire MedEuropa Romania, a renowned cancer care provider.

Global Pharma | 04/03/2024 | By Manvi |  550

Hugel Receives US FDA Approval for Its Botulinum Toxin Letybo

Hugel announced that the company has received marketing approval from the U.S. Food and Drug Administration (FDA) on the 29th (local time) for 50 units and 100 units of its botulinum toxin Letybo.

Global Pharma | 04/03/2024 | By Manvi |  799

FDA Approves RYBREVANT Plus Chemotherapy for NSCLC with EGFR Exon 20 Insertion Mutations

This approval, following a priority review, builds upon the accelerated approval of RYBREVANT® in May 2021, based on the Phase 3 PAPILLON study results.

Global Pharma | 02/03/2024 | By Manvi |  622

Dr. Rahul Rathod Named Global Principal Investigator for Mezzion Pharmaceuticals' FUEL-2 Trial

Dr. Rathod, a distinguished pediatric cardiology specialist with over two decades of expertise at Boston Children's Hospital, brings extensive experience to this crucial role.

Global Pharma | 02/03/2024 | By Manvi |  954

Ginkgo Bioworks Acquires Reverie Labs to Strengthen AI-Driven Drug Discovery

This strategic move aims to enhance Ginkgo's capabilities in AI-driven drug discovery and advance its efforts in developing next-generation biological foundation models.

Global Pharma | 01/03/2024 | By Manvi |  1033